Page 8 - Diffusion Pharmaceuticals News Today

Diffusion Pharmaceuticals (NASDAQ:DFFN – Get Rating) is scheduled to post its quarterly earnings results on Friday, March 24th. Diffusion Pharmaceuticals Stock Performance Shares of DFFN stock traded down $0.19 on Thursday, hitting $5.65. The company had a trading volume of 4,032 shares, compared to its average volume of 7,947. The firm has a market cap […]

Diffusion Pharmaceuticals (NASDAQ:DFFN – Get Rating) will announce its earnings results on Friday, March 24th. Diffusion Pharmaceuticals Stock Down 3.3 % Diffusion Pharmaceuticals stock traded down $0.19 during mid-day trading on Thursday, reaching $5.65. 4,032 shares of the company’s stock were exchanged, compared to its average volume of 7,947. The business’s fifty day simple moving […]

Should You Buy or Sell Diffusion Pharmaceuticals Stock? Get The Latest DFFN Stock Forecast, Price Target, Earnings Estimates, Headlines, Short Interest at MarketBeat.

Analysts at StockNews.com began coverage on shares of Diffusion Pharmaceuticals (NASDAQ:DFFN – Get Rating) in a report released on Thursday. The firm set a “hold” rating on the stock. Diffusion Pharmaceuticals Stock Up 0.3 % Shares of Diffusion Pharmaceuticals stock opened at $5.36 on Thursday. Diffusion Pharmaceuticals has a twelve month low of $4.64 and […]

(RTTNews) - Biopharmaceutical company Diffusion Pharmaceuticals Inc. (DFFN) said Monday in a letter to its stockholders that the Companys board o...

Sets the Record Straight on Diffusion’s Misleading Narrative and Raises Concerns about a Troubling Pattern of Entrenchment and Lack of Accountability on...

KEY POINTS The first known diagnosis of SARS-CoV-2 infection in Canada was in a patient in hospital in Toronto on Jan. 25, 2020.[1][1] At the time, few anticipated the intensity and duration of the COVID-19 pandemic, which has presented health systems and governments globally with challenges not

Diffusion Pharmaceuticals Inc. (NASDAQ:DFFN – Get Rating) was the target of a large decline in short interest during the month of May. As of May 31st, there was short interest totalling 87,200 shares, a decline of 28.8% from the May 15th total of 122,400 shares. Based on an average daily volume of 85,800 shares, the […]

Diffusion Pharmaceuticals Inc. (NASDAQ:DFFN – Get Rating) was the recipient of a large growth in short interest during the month of May. As of May 15th, there was short interest totalling 122,400 shares, a growth of 47.5% from the April 30th total of 83,000 shares. Based on an average trading volume of 83,700 shares, the […]

Life sciences organizations and companies strengthen their leadership teams and boards with these Movers & Shakers.